Trials / Completed
CompletedNCT00465621
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xalatan |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2007-07-01
- First posted
- 2007-04-25
- Last updated
- 2008-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00465621. Inclusion in this directory is not an endorsement.